DOCSLIB.ORG

Mouse Pcdhb5 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Pcdhb5 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Pcdhb5 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Pcdhb5 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Pcdhb5 gene (NCBI Reference Sequence: NM_053130 ; Ensembl: ENSMUSG00000063687 ) is located on Mouse chromosome 18. 1 exon is identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 1 (Transcript: ENSMUST00000078271). Exon 1 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Pcdhb5 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-480H17 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 1 covers 100.0% of the coding region. Start codon is in exon 1, and stop codon is in exon 1. The size of effective cKO region: ~2409 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy gRNA region gRNA region Wildtype allele A T A T 5' G A 3' 1 Targeting vector A T A T G A Targeted allele A T A T G A Constitutive KO allele (After Cre recombination) Legends Homology arm Exon of mouse Pcdhb5 cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(8376bp) | A(29.63% 2482) | C(19.72% 1652) | T(29.43% 2465) | G(21.22% 1777) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr18 + 37317570 37320569 3000 browser details YourSeq 182 739 1442 3000 87.7% chr5 + 64620042 64620682 641 browser details YourSeq 151 697 1013 3000 86.9% chr8 - 61749419 61749747 329 browser details YourSeq 142 673 1001 3000 82.5% chr2 + 169924932 169925229 298 browser details YourSeq 142 734 1046 3000 84.4% chr16 + 33603899 33604183 285 browser details YourSeq 141 1331 1494 3000 93.3% chr12 + 20827766 20827934 169 browser details YourSeq 140 669 1009 3000 86.6% chr17 - 6880840 6881194 355 browser details YourSeq 138 1331 1481 3000 96.1% chr13 + 90901416 90901567 152 browser details YourSeq 137 749 1011 3000 89.1% chr10 + 120837707 120837970 264 browser details YourSeq 136 736 1023 3000 91.6% chr9 + 105794346 105794633 288 browser details YourSeq 135 716 1012 3000 91.6% chr10 - 126447206 126447508 303 browser details YourSeq 134 721 955 3000 86.5% chr2 + 159183964 159184210 247 browser details YourSeq 131 1331 1481 3000 93.4% chr8 - 111144505 111144655 151 browser details YourSeq 131 732 1046 3000 85.1% chr17 - 26477438 26477743 306 browser details YourSeq 131 723 1046 3000 88.0% chr11 - 115613792 115620069 6278 browser details YourSeq 131 652 1010 3000 84.6% chr10 - 126025431 126025787 357 browser details YourSeq 130 660 950 3000 85.4% chr4 - 47792845 47793138 294 browser details YourSeq 130 732 1029 3000 86.5% chrX + 94034345 94034849 505 browser details YourSeq 130 1334 1481 3000 94.0% chr8 + 106040818 106040965 148 browser details YourSeq 129 748 1004 3000 89.3% chr5 - 118350469 118350731 263 Note: The 3000 bp section upstream of Exon 1 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr18 + 37322946 37325945 3000 browser details YourSeq 532 1681 2753 3000 89.2% chr18 + 37345902 37346986 1085 browser details YourSeq 248 392 723 3000 88.5% chr9 + 80082766 80083084 319 browser details YourSeq 246 392 730 3000 88.6% chr13 - 96259829 96299984 40156 browser details YourSeq 242 339 723 3000 87.9% chr5 - 28549980 28550461 482 browser details YourSeq 239 387 722 3000 87.7% chrX - 95810679 95811004 326 browser details YourSeq 238 392 709 3000 89.6% chr13 - 93227599 93227912 314 browser details YourSeq 237 392 720 3000 86.7% chr15 + 3454457 3454773 317 browser details YourSeq 236 392 728 3000 85.8% chr8 + 91972162 91972470 309 browser details YourSeq 235 389 721 3000 87.2% chr10 + 115522709 115523036 328 browser details YourSeq 233 392 733 3000 88.9% chr10 + 29616191 29948690 332500 browser details YourSeq 232 392 723 3000 87.9% chr9 - 49093142 49093461 320 browser details YourSeq 231 392 722 3000 87.4% chr10 + 23094031 23094350 320 browser details YourSeq 230 392 723 3000 85.9% chr8 - 42833500 42833817 318 browser details YourSeq 230 389 709 3000 86.3% chr14 + 120448741 120449044 304 browser details YourSeq 229 392 722 3000 85.5% chr7 - 101166119 101166436 318 browser details YourSeq 229 392 723 3000 85.3% chr2 - 136652877 136653190 314 browser details YourSeq 229 392 722 3000 87.4% chr12 - 98212207 98212525 319 browser details YourSeq 229 392 722 3000 86.4% chr14 + 63324270 63324586 317 browser details YourSeq 229 389 723 3000 85.4% chr10 + 21509092 21509416 325 Note: The 3000 bp section downstream of Exon 1 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Pcdhb5 protocadherin beta 5 [ Mus musculus (house mouse) ] Gene ID: 93876, updated on 11-Sep-2019 Gene summary Official Symbol Pcdhb5 provided by MGI Official Full Name protocadherin beta 5 provided by MGI Primary source MGI:MGI:2136739 See related Ensembl:ENSMUSG00000063687 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as PcdhbE; Pcdhb4A Genomic context Location: 18; 18 B3 See Pcdhb5 in Genome Data Viewer Exon count: 1 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 18 NC_000084.6 (37320381..37323913) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 18 NC_000084.5 (37480035..37483567) Chromosome 18 - NC_000084.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 1 transcript Gene: Pcdhb5 ENSMUSG00000063687 Description protocadherin beta 5 [Source:MGI Symbol;Acc:MGI:2136739] Gene Synonyms Pcdhb4A, PcdhbE Location Chromosome 18: 37,320,381-37,323,915 forward strand. GRCm38:CM001011.2 About this gene This gene has 1 transcript (splice variant), 79 orthologues, 69 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Pcdhb5-201 ENSMUST00000078271.3 3535 792aa ENSMUSP00000077389.2 Protein coding CCDS29173 Q91XZ5 TSL:NA GENCODE basic APPRIS P1 23.54 kb Forward strand 37.315Mb 37.320Mb 37.325Mb 37.330Mb Genes Gm37388-201 >protein coding (Comprehensive set... Gm42416-201 >protein coding Pcdhb4-201 >protein coding Pcdhb5-201 >protein coding Gm37013-201 >protein coding Contigs AC020974.4 > Regulatory Build 37.315Mb 37.320Mb 37.325Mb 37.330Mb Reverse strand 23.54 kb Regulation Legend CTCF Promoter Flank Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000078271 3.54 kb Forward strand Pcdhb5-201 >protein coding ENSMUSP00000077... Transmembrane heli... Low complexity (Seg) Cleavage site (Sign... Superfamily Cadherin-like superfamily SMART Cadherin-like Prints Cadherin-like Pfam Cadherin, N-terminal Cadherin, cytoplasmic C-terminal domain Cadherin-like PROSITE profiles PS50268 PROSITE patterns Cadherin conserved site PANTHER Protocadherin beta-4 PTHR24028 Gene3D 2.60.40.60 CDD cd11304 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 80 160 240 320 400 480 560 640 792 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
    Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected].
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Supporting Information Supplementary Methods Patients for Whole Genome Sequencing and Validation Cohort. Heparinized Bone Marrow
    Supporting Information Supplementary Methods Patients for whole genome sequencing and validation cohort. Heparinized bone marrow samples were obtained from 8 RAEB patients with informed consent for WGS according to the ethics review board of Shanghai Institute of Hematology. Briefly, these 8 patients were 4 RAEB-1, 4 RAEB-2, 5 males, 3 females, 1 with complex karyotype, 1 with +8, 5 with normal karyotype, and classified as intermediate to very high risk level. 6 patients died 4-23 months after diagnosis of infection, hemorrhage, cerebral infarction or evolution to AML (complete information see Table S1). The validation cohort consisted of 188 various subtypes of MDS patients diagnosed and treated in Shanghai Ruijin Hospital and Shanghai No.6 People’s Hospital. All patients provided written informed consent. Bone marrow and paired buccal samples were obtained after informed consent. DNA sample preparation. Mononuclear cells (MNC) were separated by density gradient centrifugation using Ficoll in 8 RAEB patients and 188 MDS patients from validation cohort. Subsequently, CD34+ cells were isolated by magnetic cell separation (Miltenyi Biotech, Bergisch Gladbach, Germany) to reach a purity of 89-97.7% (average: 93.1%) in 8 RAEB patients. Flow through CD34- cells were also collected for analysis. Skin biopsy was obtained for analysis of normal genome and extracted by DNeasy Blood & Tissue Kit (Qiagen). Genomic DNA of CD34+ cells were isolated by QuickGene DNA whole blood kit L (FUJIFILM, Life Science). Genomic DNA of MNC from validation set was extracted by Wizard® Genomic DNA Purification Kit (Promega). DNA library preparation. Genomic DNA was sheared by sonication 1 and adaptors were ligated to the resulting fragments.
    [Show full text]
  • Data-Independent Acquisition Method for Ubiquitinome Analysis Reveals Regulation of Circadian Biology
    ARTICLE https://doi.org/10.1038/s41467-020-20509-1 OPEN Data-independent acquisition method for ubiquitinome analysis reveals regulation of circadian biology Fynn M. Hansen1, Maria C. Tanzer1, Franziska Brüning 1,2, Isabell Bludau1, Che Stafford3, ✉ ✉ ✉ Brenda A. Schulman 4, Maria S. Robles 2 , Ozge Karayel 1 & Matthias Mann 1 1234567890():,; Protein ubiquitination is involved in virtually all cellular processes. Enrichment strategies employing antibodies targeting ubiquitin-derived diGly remnants combined with mass spectrometry (MS) have enabled investigations of ubiquitin signaling at a large scale. However, so far the power of data independent acquisition (DIA) with regards to sensitivity in single run analysis and data completeness have not yet been explored. Here, we develop a sensitive workflow combining diGly antibody-based enrichment and optimized Orbitrap- based DIA with comprehensive spectral libraries together containing more than 90,000 diGly peptides. This approach identifies 35,000 diGly peptides in single measurements of proteasome inhibitor-treated cells – double the number and quantitative accuracy of data dependent acquisition. Applied to TNF signaling, the workflow comprehensively captures known sites while adding many novel ones. An in-depth, systems-wide investigation of ubiquitination across the circadian cycle uncovers hundreds of cycling ubiquitination sites and dozens of cycling ubiquitin clusters within individual membrane protein receptors and transporters, highlighting new connections between metabolism and circadian regulation. 1 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. 2 Institute of Medical Psychology, Faculty of Medicine, LMU, Munich, Germany. 3 Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany. ✉ 4 Department of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany.
    [Show full text]
  • PCDHB5 (NM 015669) Human Tagged ORF Clone – RC200848
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC200848 PCDHB5 (NM_015669) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: PCDHB5 (NM_015669) Human Tagged ORF Clone Tag: Myc-DDK Symbol: PCDHB5 Synonyms: PCDH-BETA5 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 6 PCDHB5 (NM_015669) Human Tagged ORF Clone – RC200848 ORF Nucleotide >RC200848 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGAGACTGCGCTAGCAAAAACGCCACAGAAAAGGCAAGTTATGTTTCTTGCTATATTGTTGCTTTTGT GGGAGGCTGGCTCTGAGGCAGTTAGGTATTCCATACCAGAAGAAACAGAAAGTGGCTATTCTGTGGCCAA CCTGGCAAAAGACCTGGGTCTTGGGGTGGGGGAACTGGCCACTCGGGGCGCGCGAATGCATTACAAAGGA AACAAAGAGCTCTTGCAGCTTGATATAAAGACCGGCAATTTGCTTCTATATGAAAAACTAGACCGGGAGG TGATGTGCGGGGCGACAGAACCCTGTATATTGCATTTCCAGCTCTTACTAGAAAATCCAGTGCAGTTTTT TCAAACTGATCTGCAGCTCACAGATATAAATGACCATGCCCCAGAGTTCCCAGAGAAGGAAATGCTCCTA AAAATCCCAGAGAGCACCCAGCCAGGGACTGTGTTTCCCTTAAAAATAGCCCAGGACTTTGACATAGGTA GCAACACTGTTCAGAACTACACAATCAGCCCAAATTCACACTTTCATGTTGCTACGCATAATCGCGGAGA TGGCAGAAAATACCCAGAGCTGGTGCTGGACAAAGCGCTGGACCGGGAGGAGCGGCCTGAGCTCAGCTTA
    [Show full text]
  • A Long Non‐Coding RNA (Lrap) Modulates Brain Gene Expression
    Received: 9 June 2020 Revised: 20 August 2020 Accepted: 1 September 2020 DOI: 10.1111/gbb.12698 ORIGINAL ARTICLE A long non-coding RNA (Lrap) modulates brain gene expression and levels of alcohol consumption in rats Laura M. Saba1 | Paula L. Hoffman1,2 | Gregg E. Homanics3 | Spencer Mahaffey1 | Swapna Vidhur Daulatabad4 | Sarath Chandra Janga4,5,6 | Boris Tabakoff1 1Department of Pharmaceutical Sciences, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA 2Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA 3Departments of Anesthesiology, Neurobiology and Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA 4Department of BioHealth Informatics, Indiana University School of Informatics and Computing, Indiana University–Purdue University Indianapolis, Indianapolis, Indiana, USA 5Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA 6Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA Correspondence Boris Tabakoff, Department of Pharmaceutical Abstract Sciences, Skaggs School of Pharmacy & LncRNAs are important regulators of quantitative and qualitative features of the Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 transcriptome. We have used QTL and other statistical analyses to identify a gene E. Montview Blvd., Aurora, CO 80045. coexpression module associated with alcohol consumption. The “hub gene” of this Email: [email protected] module, Lrap (Long non-coding RNA for alcohol preference), was an unannotated Funding information transcript resembling a lncRNA. We used partial correlation analyses to establish that Banbury Fund; Ethanol Mechanisms in GABAAR gene targeted mice, Grant/Award Lrap is a major contributor to the integrity of the coexpression module.
    [Show full text]
  • Enhanced Hemato-Endothelial Specification During Human Embryonic Differentiation Through Developmental Cooperation Between AF4-MLL and MLL-AF4 Fusions
    Acute Lymphoblastic Leukemia SUPPLEMENTARY APPENDIX Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions Clara Bueno, 1,2 Fernando J Calero-Nieto, 3 Xiaonan Wang, 3 Rafael Valdés-Mas, 4 Francisco Gutiérrez-Agüera, 1 Heleia Roca-Ho, 1 Veronica Ayllon, 5 Pedro J Real, 5 David Arambilet, 6 Lluis Espinosa, 6,2 Raul Torres-Ruiz, 1 Antonio Agraz- Doblas, 1,7 Ignacio Varela, 7 Jasper de Boer, 8 Anna Bigas, 6,2 Bertie Gottgens, 3 Rolf Marschalek 9 and Pablo Menendez 1,2,10 1Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain; 2Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain; 3Department of Hematology, Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, UK; 4Dreamgenics S.L. Oviedo. Spain; 5GENyO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalu - sian Regional Government and University of Granada, Department of Biochemistry and Molecular Biology, Granada, Spain; 6Programa de Cáncer, Instituto Hospital del Mar de Investigaciones Médicas. Barcelona. Spain; 7Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain; 8Cancer Section, UCL Great Ormond Street Institute of Child Health, London, UK; 9Institute of Pharmaceutical Biology, Goethe-University, Frankfurt, Ger - many and 10 Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain ©2019 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2018.202044 Received: July 18, 2018.
    [Show full text]
  • Integrative Network Analysis for Survival-Associated Gene-Gene Interactions Across Multiple Genomic Profiles in Ovarian Cancer
    Jeong et al. Journal of Ovarian Research (2015) 8:42 DOI 10.1186/s13048-015-0171-1 RESEARCH Open Access Integrative network analysis for survival- associated gene-gene interactions across multiple genomic profiles in ovarian cancer Hyun-hwan Jeong, Sangseob Leem, Kyubum Wee and Kyung-Ah Sohn* Abstract Background: Recent advances in high-throughput technology and the emergence of large-scale genomic datasets have enabled detection of genomic features that affect clinical outcomes. Although many previous computational studies have analysed the effect of each single gene or the additive effects of multiple genes on the clinical outcome, less attention has been devoted to the identification of gene-gene interactions of general type that are associated with the clinical outcome. Moreover, the integration of information from multiple molecular profiles adds another challenge to this problem. Recently, network-based approaches have gained huge popularity. However, previous network construction methods have been more concerned with the relationship between features only, rather than the effect of feature interactions on clinical outcome. Methods: We propose a mutual information-based integrative network analysis framework (MINA) that identifies gene pairs associated with clinical outcome and systematically analyses the resulting networks over multiple genomic profiles. We implement an efficient non-parametric testing scheme that ensures the significance of detected gene interactions. We develop a tool named MINA that automates the proposed analysis scheme of identifying outcome- associated gene interactions and generating various networks from those interacting pairs for downstream analysis. Results: We demonstrate the proposed framework using real data from ovarian cancer patients in The Cancer Genome Atlas (TCGA).
    [Show full text]
  • Predict AID Targeting in Non-Ig Genes Multiple Transcription Factor
    Downloaded from http://www.jimmunol.org/ by guest on September 26, 2021 is online at: average * The Journal of Immunology published online 20 March 2013 from submission to initial decision 4 weeks from acceptance to publication Multiple Transcription Factor Binding Sites Predict AID Targeting in Non-Ig Genes Jamie L. Duke, Man Liu, Gur Yaari, Ashraf M. Khalil, Mary M. Tomayko, Mark J. Shlomchik, David G. Schatz and Steven H. Kleinstein J Immunol http://www.jimmunol.org/content/early/2013/03/20/jimmun ol.1202547 Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/suppl/2013/03/20/jimmunol.120254 7.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 26, 2021. Published March 20, 2013, doi:10.4049/jimmunol.1202547 The Journal of Immunology Multiple Transcription Factor Binding Sites Predict AID Targeting in Non-Ig Genes Jamie L. Duke,* Man Liu,†,1 Gur Yaari,‡ Ashraf M. Khalil,x Mary M. Tomayko,{ Mark J. Shlomchik,†,x David G.
    [Show full text]
  • Thousands of Cpgs Show DNA Methylation Differences in ACPA-Positive Individuals
    G C A T T A C G G C A T genes Article Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals Yixiao Zeng 1,2, Kaiqiong Zhao 2,3, Kathleen Oros Klein 2, Xiaojian Shao 4, Marvin J. Fritzler 5, Marie Hudson 2,6,7, Inés Colmegna 6,8, Tomi Pastinen 9,10, Sasha Bernatsky 6,8 and Celia M. T. Greenwood 1,2,3,9,11,* 1 PhD Program in Quantitative Life Sciences, Interfaculty Studies, McGill University, Montréal, QC H3A 1E3, Canada; [email protected] 2 Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada; [email protected] (K.Z.); [email protected] (K.O.K.); [email protected] (M.H.) 3 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC H3A 1A2, Canada 4 Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada; [email protected] 5 Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada; [email protected] 6 Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada; [email protected] (I.C.); [email protected] (S.B.) 7 Division of Rheumatology, Jewish General Hospital, Montréal, QC H3T 1E2, Canada 8 Division of Rheumatology, McGill University, Montréal, QC H3G 1A4, Canada 9 Department of Human Genetics, McGill University, Montréal, QC H3A 0C7, Canada; [email protected] 10 Center for Pediatric Genomic Medicine, Children’s Mercy, Kansas City, MO 64108, USA 11 Gerald Bronfman Department of Oncology, McGill University, Montréal, QC H4A 3T2, Canada * Correspondence: [email protected] Citation: Zeng, Y.; Zhao, K.; Oros Abstract: High levels of anti-citrullinated protein antibodies (ACPA) are often observed prior to Klein, K.; Shao, X.; Fritzler, M.J.; Hudson, M.; Colmegna, I.; Pastinen, a diagnosis of rheumatoid arthritis (RA).
    [Show full text]
  • An RNA Matchmaker Protein Regulates the Activity of the Long Noncoding RNA HOTAIR
    Downloaded from rnajournal.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press An RNA matchmaker protein regulates the activity of the long noncoding RNA HOTAIR EMILY K. MEREDITH,1,3 MAGGIE M. BALAS,1,2,3 KARLA SINDY,1 KRYSTAL HAISLOP,1 and AARON M. JOHNSON1,2 1Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado 80045, USA 2Molecular Biology Program, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045, USA ABSTRACT The human long noncoding RNA (lncRNA) HOTAIR acts in trans to recruit the Polycomb repressive complex 2 (PRC2) to the HOXD gene cluster and to promote gene silencing during development. In breast cancers, overexpression of HOTAIR increases metastatic potential via the repression of many additional genes. It has remained unclear what factors determine HOTAIR-dependent PRC2 activity at specific genomic loci, particularly when high levels of HOTAIR result in aberrant gene silencing. To identify additional proteins that contribute to the specific action of HOTAIR, we performed a quantitative proteomic analysis of the HOTAIR interactome. We found that the most specific interaction was between HOTAIR and the heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1, a member of a family of proteins involved in nascent mRNA processing and RNA matchmaking. Our data suggest that A2/B1 are key contributors to HOTAIR-mediated chromatin regulation in breast cancer cells: A2/B1 knockdown reduces HOTAIR-dependent breast cancer cell invasion and decreases PRC2 activity at the majority of HOTAIR-dependent loci. We found that the B1 isoform, which differs from A2 by 12 additional amino acids, binds with highest specificity to HOTAIR.
    [Show full text]
  • Genome-Wide Gene Expression Profiling of Randall's Plaques In
    CLINICAL RESEARCH www.jasn.org Genome-Wide Gene Expression Profiling of Randall’s Plaques in Calcium Oxalate Stone Formers † † Kazumi Taguchi,* Shuzo Hamamoto,* Atsushi Okada,* Rei Unno,* Hideyuki Kamisawa,* Taku Naiki,* Ryosuke Ando,* Kentaro Mizuno,* Noriyasu Kawai,* Keiichi Tozawa,* Kenjiro Kohri,* and Takahiro Yasui* *Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; and †Department of Urology, Social Medical Corporation Kojunkai Daido Hospital, Daido Clinic, Nagoya, Japan ABSTRACT Randall plaques (RPs) can contribute to the formation of idiopathic calcium oxalate (CaOx) kidney stones; however, genes related to RP formation have not been identified. We previously reported the potential therapeutic role of osteopontin (OPN) and macrophages in CaOx kidney stone formation, discovered using genome-recombined mice and genome-wide analyses. Here, to characterize the genetic patho- genesis of RPs, we used microarrays and immunohistology to compare gene expression among renal papillary RP and non-RP tissues of 23 CaOx stone formers (SFs) (age- and sex-matched) and normal papillary tissue of seven controls. Transmission electron microscopy showed OPN and collagen expression inside and around RPs, respectively. Cluster analysis revealed that the papillary gene expression of CaOx SFs differed significantly from that of controls. Disease and function analysis of gene expression revealed activation of cellular hyperpolarization, reproductive development, and molecular transport in papillary tissue from RPs and non-RP regions of CaOx SFs. Compared with non-RP tissue, RP tissue showed upregulation (˃2-fold) of LCN2, IL11, PTGS1, GPX3,andMMD and downregulation (0.5-fold) of SLC12A1 and NALCN (P,0.01). In network and toxicity analyses, these genes associated with activated mitogen- activated protein kinase, the Akt/phosphatidylinositol 3-kinase pathway, and proinflammatory cytokines that cause renal injury and oxidative stress.
    [Show full text]